Search

everythinglearnresearchcommunity

for

Search:↓

An 87-year-old man showed unusual signs of Hodgkin lymphoma, primarily high calcium levels, which improved after treatment and revealed the disease.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Hodgkin's lymphoma can show up as hair loss.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Using hair dye may slightly increase the risk of non-Hodgkin's lymphoma, especially with long-term use.

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.

The albumin change rate helps predict treatment success in AIDS-related non-Hodgkin lymphoma.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Alopecia areata is linked to blood cancers, especially in older patients, but not to most solid cancers.

The document concludes that there is no credible evidence that distant healing works, and it should not be further studied in medical literature.

Patients with cutaneous lupus erythematosus have a higher risk of skin cancer and other cancers.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

An elderly woman's swollen, painful foot was found to be caused by a rare type of bone lymphoma, which improved with radiation treatment.

Hair loss may be an early sign of serious illnesses like Hodgkin disease.

CHOP chemotherapy causes many side effects but is generally well tolerated.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Dermatological drugs and cosmetics can cause serious side effects like cancer, allergies, and heart issues.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.